EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Estimation of the maximum potential cost saving from reducing serious adverse events in hospitalized patients

Arendse Tange Larsen iD, Liza Sopina iD, Eske Kvanner Aasvang iD, Christian Sylvest Meyhoff iD, Søren Rud Kristensen iD, Jakob Kjellberg iD

Acta Anaesthesiologica Scandinavica · 2024

DOI: 10.1111/aas.14525 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Anaesthesiologica Scandinavica, 2024. Verfasst von Arendse Tange Larsen und 5 weiteren Autor:innen. Beteiligte Einrichtung: VIVE - Health, VIVE-The Danish Center for Social Science Research, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Length of Stay, Cost Savings, Hospitalization, Patient Readmission. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Innovation Fund Denmark, Novo Nordic Foundation, Danish Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The increasing use of advanced medical technologies to detect adverse events, for instance, artificial intelligence‐assisted technologies, has shown promise in improving various aspects within health care but may also come with substantial expenses. Therefore, understanding the potential economic benefits can guide decision‐making processes regarding implementation. We aimed to estimate the potential cost savings associated with reducing length of stay and avoiding readmissions within the framework of an artificial intelligence‐assisted vital signs monitoring system.

Methods

We used data from Danish national registries and coarsened exact matching to estimate the difference in length of stay and probability of readmission among adult in‐hospital patients exposed to and not exposed to serious adverse events. We used these estimates to calculate the maximum potential savings that could be achieved by early detection of adverse events to reduce length of stay and avoid readmissions.

Results

Patients exposed to serious adverse events during admission had 2.4 (95% CI: 2.4–2.5) additional hospital bed days and had 14% (95% CI 11%–17%) higher odds of readmissions compared with patients not exposed to such events. A base case scenario yielded maximum potential savings if one patient avoided a serious adverse event of EUR 2040 due to reduced length of stay and EUR 43 due to avoidance of readmissions caused by serious adverse events.

Conclusion

Reductions in serious adverse events are associated with decreased healthcare costs due to reduced length of stay and avoided readmissions. Artificial intelligence‐assisted vital signs monitoring systems are one potential approach to reduce serious adverse events, however, the ability of this technology to reduce adverse events remains unclear. Comprehensive prospective analyses of such systems including the intervention and implementation costs are necessary to understand their full economic impact.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Length of StayCost SavingsHospitalizationPatient ReadmissionHumansMaleFemaleMiddle AgedAgedDenmarkAdultArtificial IntelligenceRegistriesAged, 80 and over

Stichwörter der Autor:innen

artificial intelligencecontinuous vital signs monitoringcost savingshealth economicserious adverse events

Autor:innen und Institutionen

  • VIVE - Health, VIVE-The Danish Center for Social Science Research, Copenhagen, Denmark.
  • Danish Center for Health Economics, University of Southern Denmark, Odense, Denmark.
  • Department of Anaesthesiology, Center for Cancer and Organ Diseases, Rigshospitalet, Copenhagen University & Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Department of Anaesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, Copenhagen, Denmark & Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • DaCHE-Danish Centre for Health Economics, University of Southern Denmark, Odense, Denmark.

ORCID-Profile: Arendse Tange Larsen, Liza Sopina, Eske Kvanner Aasvang, Christian Sylvest Meyhoff, Søren Rud Kristensen, Jakob Kjellberg

Förderung

  • Innovation Fund Denmark
  • Novo Nordic Foundation
  • Danish Cancer Society
  • Steno Diabetes Center Denmark, Copenhagen Center for Health Technology
  • A.P. Møller Foundation
  • Innovationsfonden
  • Novo Nordisk Fonden
  • Kræftens Bekæmpelse

Zitieren

APA

Larsen, A. T., Sopina, L., Aasvang, E. K., Meyhoff, C. S., Kristensen, S. R., & Kjellberg, J. (2024). Estimation of the maximum potential cost saving from reducing serious adverse events in hospitalized patients. Acta Anaesthesiologica Scandinavica. https://doi.org/10.1111/aas.14525

Vancouver

Larsen AT, Sopina L, Aasvang EK, Meyhoff CS, Kristensen SR, Kjellberg J. Estimation of the maximum potential cost saving from reducing serious adverse events in hospitalized patients. Acta Anaesthesiologica Scandinavica. 2024. doi:10.1111/aas.14525

BibTeX
@article{Larsen2024,
  author = {Larsen, Arendse Tange and Sopina, Liza and Aasvang, Eske Kvanner and Meyhoff, Christian Sylvest and Kristensen, Søren Rud and Kjellberg, Jakob},
  title = {Estimation of the maximum potential cost saving from reducing serious adverse events in hospitalized patients},
  journal = {Acta Anaesthesiologica Scandinavica},
  year = {2024},
  doi = {10.1111/aas.14525}
}
Kostenlos starten →